Almenciol, Fe C.
HRN: 02 65 00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/24/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/24/2022
12/30/2022
IV
600mg
Q8
Soft Tissue Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes